Moderna Inc (MRNA)
120.10
-2.04
(-1.67%)
USD |
NASDAQ |
May 07, 14:43
Moderna Total Liabilities (Quarterly): 3.912B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.912B |
December 31, 2023 | 4.572B |
September 30, 2023 | 5.995B |
June 30, 2023 | 4.935B |
March 31, 2023 | 5.262B |
December 31, 2022 | 6.735B |
September 30, 2022 | 8.064B |
June 30, 2022 | 8.058B |
March 31, 2022 | 10.53B |
December 31, 2021 | 10.52B |
September 30, 2021 | 10.80B |
June 30, 2021 | 9.449B |
Date | Value |
---|---|
March 31, 2021 | 8.856B |
December 31, 2020 | 4.776B |
September 30, 2020 | 1.891B |
June 30, 2020 | 539.12M |
March 31, 2020 | 426.67M |
December 31, 2019 | 414.61M |
September 30, 2019 | 339.09M |
June 30, 2019 | 346.72M |
March 31, 2019 | 360.17M |
December 31, 2018 | 431.91M |
September 30, 2018 | 412.73M |
December 31, 2017 | 459.19M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
339.09M
Minimum
Sep 2019
10.80B
Maximum
Sep 2021
5.321B
Average
5.098B
Median
Total Liabilities (Quarterly) Benchmarks
Merck & Co Inc | 65.42B |
Pfizer Inc | 137.21B |
Eli Lilly and Co | 51.05B |
Johnson & Johnson | 101.95B |
Novavax Inc | 2.514B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 16.73B |
Shareholders Equity (Quarterly) | 12.82B |
Current Ratio | 4.034 |